Previously undiagnosed anaemia is common in elective orthopaedic surgical patients and is
associated with increased likelihood of blood transfusion and increased perioperative …

Background Anaemia associated with cancer and cancer therapy is an important clinical
factor in the treatment of malignant diseases. Therapeutic alternatives are recombinant …

Anemia is prevalent in 30% to 90% of patients with cancer. Anemia can be corrected
through either treating the underlying cause or providing supportive care through transfusion …

Pharmacological treatments for fatigue associated with palliative care - Mücke, M - 2015 |
Cochrane Library Skip to Content Cookies Our site uses cookies to improve your experience …

BACKGROUND: Cancer patients often develop the potentially debilitating condition of
anaemia. Numerous controlled studies indicate that erythropoiesis-stimulating agents …

Abstract Purpose: To update American Society of Hematology/American Society of Clinical
Oncology recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients …

Inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6),
among others, play a major role in the pathophysiology of anemia in the cancer patient not …

Chemotherapy-induced anemia (CIA) is a multifaceted entity influenced by a variety of
patient-and treatment-specific factors. Some sources of variation within CIA include …

Causes of anaemia in cancer patients might be patient-(eg haemoglobinopathies,
thalassaemia, diminished nutritional status with deficiencies); disease-(bone marrow …

Purpose To update American Society of Clinical Oncology/American Society of Hematology
recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients with …